COVID-19

The US ranks first in the world in vaccines administered.

Headache was the most prominent link between COVID-19 and depression.

COVID-19-associated AKI patients had fewer comorbidities compared to AKI patients without the viral infection.

The US has an underreported and perpetuating issue with clinician burnout and suicidality. Frontline caregivers consider what 1 year of a pandemic may have done to worsen it.

Researchers see differences in how COVID-19 attacks the brain in comparison to the influenza virus that caused the 1918 pandemic.

Guidelines reflect updated guidance from the CDC and FDA.

Approximately 50% of COVID-19 patients have some form of gastrointestinal symptoms.

COVID-19 has provided an opportunity for clinicians and specialists to reevaluate what it truly means to bring care to their patients.

The pandemic had an immediate effect on patient care, and in pivoting to adapt to the quarantine, some changes may have created potentially permanent ways to deliver health care.

Nearly 60% of children with MIS-C are admitted to the hospital for intensive care.

Management of the painkiller addiction crisis looked optimistic headed into 2020. The pandemic brought a heavy toll to efforts that took years to establish.

Guidelines call for athletes to miss up 6 months of sports following a myocarditis diagnosis. How frequent is the condition in the era of a risk-driving pandemic?

Vaccinated people may now meet indoors with low-risk unvaccinated individuals without masks or social distancing.

While at low-risk for severe COVID-19 disease course, children face risks of mental, social, emotional, and physical impact from the pandemic. Is healthcare ready to respond?

For decades, the drug class has been a highly promising yet selectively used agent in a litany of disease. Its necessity in the pandemic has provided lessons in how it could be utilized in the future.

Students share their experience in the virtual classroom, navigating new requirements, and the lessons learned from their position in a global pandemic.

In this 9-part series, we explore how the COVID-19 pandemic may permanently change health care, treatment, and research in the future.

Sleep has increased since the beginning of the pandemic in college students, while social activity has decreased.

Researchers see differences in how SARS-CoV-2 attacks the brain in comparison to the influenza virus that caused the 1918 pandemic.

The FDA recently issued the third EUA for a COVID-19 vaccine in the US.

From interpreting currently-understood risks to managing isolation-induced indoor allergen exposure, asthmatics may have concerns they address with clinicians.

Surveyed patients discharged from the hospital are reporting respiratory burdens beyond 6 months. Are outpatient facilities equipped to manage COVID-19 long haulers?

A review of 3 new studies, which indicate the association between severe COVID-19 and the chronic disease is more intricate than previously thought.

Oxygen saturation levels similar for both asthma patients and non-asthma patients following mask use.

Trials testing hydroxychloroquine against COVID-19 have produced mixed results.

New survey results depict unexpected burdens in long-haul patients, as well as continued issues following rehabilitation.

All patients in the study who tested positive for COVID-19 suffered from mild or moderate symptoms.

The authors of a research letter say a small minority of patients with diabetes have facial pain that cannot otherwise be easily explained.

The Ad26 platform has been used in vaccines administered to nearly 200,000 real-world and clinical trial participants